Follow-up Evaluation of Photo-Dynamic Therapy for Pituitary Tumours
NCT02632084 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2015-12-16
Summary
A study to followup patients that have previously been treated for pituitary tumours with either photodynamic therapy or placebo in a previous trial. The study aims to determine whether photodynamic therapy has any long term effect on tumour size, visual fields or endocrinological function.
Conditions
- Pituitary Neoplasms
Sponsors & Collaborators
-
The Leeds Teaching Hospitals NHS Trust
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-31
- Primary Completion
- 2010-09-30
- Completion
- 2011-09-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma.
NCT01283542 ·Status: COMPLETED ·Phase: PHASE2
-
Seoul National University Pituitary Disease Cohort Study
NCT03474601 ·Status: UNKNOWN
-
Intraoperative Imaging of Pituitary Adenomas by OTL
NCT02629549 ·Status: TERMINATED ·Phase: PHASE1
-
Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
NCT01775332 ·Status: UNKNOWN ·Phase: NA
-
Transnasal Endoscopic Pituitary Surgery - the Effect of Posterior Nasal Septum Resection on Nasal Functions
NCT04782596 ·Status: COMPLETED ·Phase: NA
-
Prospective Quality of Life Study in Pituitary Surgery
NCT03694990 ·Status: UNKNOWN
-
Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors
NCT06679816 ·Status: RECRUITING ·Phase: PHASE4
-
Intraoperative Ultrasound in Patients Undergoing Transsphenoidal Surgery for Pituitary Adenoma
NCT03284775 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
NCT07335315 ·Status: RECRUITING
-
Prediction of Tumor Shrinkage in Acromegaly
NCT00616408 ·Status: COMPLETED
-
The Treatment and Natural History of Acromegaly
NCT00001981 ·Status: COMPLETED
-
Acromegaly Combination Treatment Study
NCT01538966 ·Status: TERMINATED ·Phase: NA
-
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
NCT00376064 ·Status: COMPLETED ·Phase: PHASE4
-
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
NCT00097513 ·Status: COMPLETED
-
Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
NCT00646308 ·Status: TERMINATED
-
Acromegaly Treatment Quality of Life Study
NCT01732406 ·Status: COMPLETED
-
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
NCT04076462 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Study With ITF2984 in Acromegalic Patients
NCT02111044 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome
NCT02705014 ·Status: UNKNOWN ·Phase: NA
-
Transsphenoidal Extent of Resection Study
NCT02357498 ·Status: COMPLETED ·Phase: NA
-
Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly
NCT00372697 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma
NCT03439709 ·Status: UNKNOWN ·Phase: PHASE3
-
Long Term Outcome Study in Patients With Pituitary Disorders
NCT03665064 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease
NCT04339751 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas
NCT00929669 ·Status: TERMINATED ·Phase: PHASE2